A synthetic melanocortin receptor agonist widely studied for its role in melanocortin signaling pathways involved in neuroendocrine and physiological research.
Leave your email and our team will contact you about PT-141.
These products are intended for research and laboratory use only. Not intended for human or veterinary use. Not for diagnostic or therapeutic procedures. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Estimate delivery times: 12-26 days (International), 3-6 days (United States).
A synthetic melanocortin receptor agonist widely studied for its role in melanocortin signaling pathways involved in neuroendocrine and physiological research.
Key Benefits: Supports research into melanocortin receptor activity, neuroendocrine signaling, physiological response mechanisms, and receptor pathway modulation.
PT-141 is typically administered under medical supervision, with dosing protocols tailored to individual health goals and clinical evaluation.
Combined GHRH and Growth Hormone Secretagogue for a balanced, sustained growth hormone response.
A mitochondrial-derived peptide studied for its role in metabolic flexibility, muscle preservation, and energy regulation.
A targeted protocol inspired by rapid healing, focusing on connective tissue integrity, circulation, and muscle recovery.
A GLP-1 receptor agonist that mimics naturally occurring incretin hormones, making it a valuable tool for metabolic and endocrine research.
This website contains research compounds for laboratory use only
By entering this site, you confirm that:
Legal Notice: All products are for research use only and are not FDA-approved for human or veterinary use.